Endo Pharmaceuticals Holdings (ENDP) Tops Q4 EPS by 7c, Reaffirms Outlook
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Selling, general and administrative: 159.9M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Selling, general and administrative: 159.9M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q4 EPS of $1.62, $0.07 better than the analyst estimate of $1.55. Revenue for the quarter came in at $801.1 million versus the consensus estimate of $807.98 million. Endo Pharmaceuticals Holdings reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Endo Pharmaceuticals Holdings (ENDP) click here.
For earnings history and earnings-related data on Endo Pharmaceuticals Holdings (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- FS Bancorp (FSBW) Tops Q1 EPS by 8c
- Newmarket (NEU) Reports Q1 EPS of $11.23
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!